Bharat Biotech Says Covaxin At Rs 150 A Dose To Centre "Not Sustainable"
The supply price of Bharat Biotech's COVID-19 vaccine Covaxin to the central government at Rs 150 per dose is not sustainable in the long run, the vaccine maker said on Tuesday.
No comments:
Post a Comment